Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7

International Journal of Molecular Sciences(2025)10.3390/ijms26104956Source: DataRank Database

Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7 is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.84)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Aidong Qi,Allie Han,Haley E. Kling,Marc Quitalig,Aaron M. Bender ORCID

Live enrichment

PubMed:40430094 PMC:PMC12112332 OpenAlex:https://openalex.org/W4410553608

William K. Warren Foundation

Grant: MH062646

National Institutes of Health

Grant: MH119673

National Institutes of Health

Grant: 7R01MH062646-04

REGULATION OF SIGNALING BY MGLUR5

National Institutes of Health

Grant: 5R01MH119673-04

Discovery of mGlu receptor PAMs for treatment of schizophrenia

National Institutes of Health

Grant: 5R01MH062464-04

Risk for Substance Abuse in Depressed Adolescents

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/26/10/4956/pdf?version=1747836489

publisherhttps://www.mdpi.com/1422-0067/26/10/4956/pdf?version=1747836489

journalhttps://doi.org/10.3390/ijms26104956

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40430094

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12112332

Fields of Study

Cannabis and Cannabinoid ResearchPancreatic function and diabetesNeurotransmitter Receptor Influence on Behavior03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsHumansLigandsMycophenolic AcidReceptor, Cannabinoid, CB2HEK293 CellsCannabinoid Receptor Agonists

Keywords

Cannabinoid receptorCannabinoid receptor type 2CannabinoidPharmacologyChemistryEndocannabinoid systemAgonistDesigner drugReceptorRadioligandSynthetic cannabinoidsMycophenolateBiologyMedicineDrugBiochemistryInternal medicineTransplantationMycophenolate MofetilAllosteric ModulatorBrain DisordersMda7Gw-842,166xCannabinoid Receptor AgonistsMedicine and PharmacologyMycophenolic AcidLigandsArticleReceptor, Cannabinoid, CB2HEK293 CellsHumansAnimals

Sustainable Development Goals

SDG 0: Good health and well-being

Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7

FAIR Checklist

Authors (10)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)